Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation

NCT03153358 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer Stage IV

Interventions

DRUG: Icotinib
RADIATION: SBRT

Sponsor

Sichuan Cancer Hospital and Research Institute